The impact of antimicrobial resistance on the treatment of sexually transmitted diseases

Infectious Disease Clinics of North America

Volumn 11, Issue 4, 1997, Pages 889-903

  Erbelding, E ^a   Quinn, T C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIINFECTIVE AGENT; FLEROXACIN; FURAZOLIDONE; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MONITORING; DRUG USE; FOLLOW UP; GENITAL HERPES; GONORRHEA; HAEMOPHILUS DUCREYI; HEALTH CARE COST; HUMAN; NEISSERIA GONORRHOEAE; PELVIC INFLAMMATORY DISEASE; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; ULCUS MOLLE;

EID: 0031467023     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70396-2     Document Type: Article

References (60)

1. W.L. Albritton L.A. MacLean A.R.R. Slaney Plasmid-mediated tetracycline resistance in Haemophilus ducreyi Antimicrob Agents Chemother 25 1989 187 190
2. J.G. Bartlett Cost of antimicrobial agents. Pocketbook of Infectious Disease Therapy 1996 Williams and Wilkins Baltimore 16 19
3. H. Birley P. MacDonald P. Carey High-level ciprofloxacin resistance in Neisseria gonorrhoeae Genitourin Med 70 1994 292 293
4. Cates W. Jr Epidemiology and control of sexually transmitted diseases in adolescents 1990 409 427
5. Centers for Disease Control and Prevention Recommended treatment schedules for gonorrhea: March 1972 MMWR 21 1972 82
6. Centers for Disease Control and Prevention Penicillin-resistant gonorrhea—North Carolina MMWR 32 1983 273 275
7. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines MMWR 42 1993 1 102
8. Centers for Disease Control and Prevention Fluoroquinolone resistance in Neisseria gonorrhoeae —Colorado and Washington, 1995 MMWR 44 1995 761 764
9. Centers for Disease Control and Prevention Ten leading nationally notifiable infectious diseases—United States, 1995 MMWR 45 1996 883 884
10. Centers for Disease Control and Prevention Sexually transmitted disease surveillance 1995 1996 Dept. of Health and Human Services, Public Health Service U.S.
11. P.A. Chatis C.S. Crumbaker Resistance of herpesviruses to antiviral drugs Antimicrob Agents Chemother 36 1992 1589 1595
12. Y. Dangor F.L. Ballard G. Exposto Accuracy of a clinical diagnosis of genital ulcer disease Sex Transm Dis 17 1990 184 189
13. M.P. Dombrowski R.J. Sokol W.J. Brown Intravenous therapy of metronidazole-resistant Trichomonas vaginalis Obstet Gynecol 69 1987 624 625
14. A.K. Field K.K. Biron “The end of innocence” revisited: Resistance of herpes virus to antiviral drugs Clin Microbiol Rev 7 1994 1 13
15. A. Gaisin C.L. Heaton Chancroid: alias the soft chancre Int J Dermatol 3 1975 188
16. S.M. Gordon C.J. Carlyn L.J. Doyle The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: Epidemiology and risk factors Ann Intern Med 125 1996 465 470
17. W.R. Gransden C.A. Warren I. Phillips Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin [letter] Lancet 335 1990 51
18. H. Grosskurth F. Mosha J. Todd Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial Lancet 346 1995 530 536
19. K.A. Hamed A.E. Studemeister Successful response of metronidazole-resistant Trichomonas vaginalis to tinidazole Sex Transm Dis 19 1992 339 340
20. G.W. Hammond M. Slutchuk J. Scatiff Clinical, epidemiological, laboratory and therapeutic features of an urban outbreak of chancroid in North America Rev Infect Dis 2 1980 267 279
21. P. Heine J.A. McGregor Trichomonas vaginalis : a re-emerging pathogen Clin Obstet Gynecol 36 1993 137 144
22. E.L. Hill G.A. Hunter M.N. Ellis In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus Antimicrob Agents Chemother 35 1991 2322 2328
23. Hook E.W. III K.K. Holmes Gonococcal infections Ann Intern Med 102 1985 229 243
24. Institute of Medicine The Hidden Epidemic: Confronting Sexually Transmitted Diseases 1997 National Academy Press Washington, DC
25. K.M. Kam K.K. Lo K.Y.H. Ng Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance Genitourin Med 71 1995 141 144
26. R.H. Kampmeier Introduction of sulfonamide therapy for gonorrhea Sex Transm Dis 10 1983 81 84
27. R.G. Kost E.L. Hill M. Tigges S.E. Straus Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient N Engl J Med 329 1993 1777 1782
28. M. Laga M. Alary N. Nzila Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers Lancet 344 1994 246 248
29. C.H. Livengood J.G. Lossick Resolution of resistant vaginal trichomoniasis with the use of intravaginal nonoxynol-9 Obstet Gynecol 7 1991 955 957
30. J.F. Mahoney C. Ferguson M. Bucholtz The use of penicillin in the treatment of sulfonamide-resistant gonorrhea in men Am J Syph Gonorr Vener Dis 27 1943 525 528
31. J.L. Marmar The management of resistant chancroid in Vietnam J Urology 107 1972 807 808
32. H.A. Minkoff A.N. Grunebaum R.H. Schwarz Risk factors for prematurity and premature rupture of membranes: a prospective study of vaginal flora in pregnancy Am J Obstet Gynecol 150 1984 965 972
33. M. Motley S.K. Sarafien J.S. Knapp Correlation between in vitro antimicrobial susceptibilities and β-lacatamase plasmid contents of isolates of Haemophilus ducreyi from the United States Antimicrob Agents Chemother 36 1992 1639 1643
34. F. Mouly M. Baccard C. Scieux Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient [letter] Dermatology 190 1995 177
35. E.M. Narcisi W.E. Secor In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis Antimicrob Agents Chemother 40 1996 1121 1125
36. National Committee for Clinical Laboratory Standards Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 4th ed. Approved standard, M7-A4 1997 National Committee for Clinical Laboratory Standards Villanova, PA
37. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th ed. Approved standard M2-A6 1997 National Committee for Clinical Laboratory Standards Villanova, Pa
38. N. O'Farrell A.A. Hoosen K.D. Coetzee Genital ulcer disease: accuracy of clinical diagnosis and strategies to improve control in Durban, South Africa Genitourin Med 70 1994 7 11
39. M. Over P. Piot HIV infection and sexually transmitted diseases in developing countries: public health importance and priorities for resource allocation J Infect Dis 174 Suppl(2) 1996 S162 S175
40. P.J. Plourde E. D'Costa J. Agoki A randomized, double-blind study of the efficacy of fleroxacin vs. trimethoprim-sulfamethoxazole in men with culture-proven chancroid J Infect Dis 165 1992 949 952
41. F.A. Plummer J.N. Simonsen D.W. Cameron Co-factors in male–female transmission of human immunodeficiency virus type 1 J Infect Dis 163 1991 233 239
42. T.C. Quinn Sexually transmitted diseases 1992 Raven Press New York
43. G.H. Reynolds A.A. Zaidi C. Thornsberry The national gonorrhea therapy monitoring study: II. Trends and seasonality of antibiotic resistance of Neisseria gonorrhoeae Sex Transm Dis 6 1979 103 111
44. M.C. Roberts L.A. Actis J.H. Crosa Molecular characterization of chloramphenicol-resistant Haemophilus parainfluenzae and Haemophilus ducreyi Antimicrob Agents Chemother 28 1985 176 180
45. S. Safrin T. Assaydeen S. Follansbee Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data J Infect Dis 161 1990 1078 1084
46. S. Safrin T. Assaydeen S. Follansbee A randomized comparison of foscarnet vs vidarabine for treatment of acyclovir-resistant mucocutaneous herpes simplex in patients with AIDS N Engl J Med 325 1991 551 555
47. Sanson-Le Pors M.J. I.M. Casin E. Collatz Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi Antimicrob Agents Chemother 28 1985 315 319
48. J.D. Schnell The incidence of vaginal candida and trichomonas infections and treatment of Trichomonas vaginalis with clotrimazole Postgrad Med J 50 1974 81 83
49. S.K. Schwarcz J.M. Zenilman D. Schnell National surveillance of antimicrobial resistance in Neisseria gonorrhoeae JAMA 264 1990 1413 1417
50. J.W. Tapsall R. Lovett R. Munro Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhea Med J Aust 156 1992 143
51. Tenover FC, Popovic T, Olsvik O: Using molecular methods to detect antimicrobial resistance genes pp. 1368–1378. In Murray PR, Baron EJ, Pfaller MA, et al (eds): Manual of Clinical Microbiology, 6th ed. Washington, DC: American Society of Microbiology
52. D.L. Trees S.A. Morse Chancroid and Haemophilus ducreyi : an update Clin Microbiol Rev 8 1995 357 375
53. J.N. Wasserheit Epidemiologic synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases Sex Transm Dis 9 1992 61 77
54. J.N. Wasserheit Effect of changes in human ecology and behavior on patterns of sexually transmitted diseases, including human immunodeficiency virus infection Proc Natl Acad Sci USA 91 1994 2430 2435
55. A. Weinberg B.J. Bates H.B. Masters In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2 Antimicrob Agents Chemother 36 1992 2037 2038
56. Whitley R.J. Anann J.W. Jr Acyclovir: A decade later N Engl J Med 327 1992 782
57. P.J. Willson W.L. Albritton L. Slaney Characterization of a multiple antibiotic resistance plasmid from Haemophilus ducreyi Antimicrob Agents Chemother 33 1989 1627 1630
58. World Bank World Development Report, 1993: Investing in Health 1993 Oxford University Press New York
59. World Health Organization: Recommendations for the management of sexually transmitted diseases. WHA/GPA/STD/93.1, 1993.
60. World Health Organization GP: Global prevalence and incidence of selected curable sexually transmitted diseases: Overview and estimates, 1996.